Academic · Private company
Translational Genomics Research Institute
Track this companyFree. Adds Translational Genomics Research Institute to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials4
- Blood and Cystic Fluid From Patients Undergoing Surgery for Worrisome Pancreatic CystsRECRUITING · started Feb 3, 2025ClinicalTrials.gov NCT07767227 · fetched Nov 12, 2026
- A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic CancerPHASE2 · COMPLETED · started Dec 27, 2017ClinicalTrials.gov NCT03331562 · fetched Nov 12, 2026
- Studies in Patients With Tuberous Sclerosis ComplexCOMPLETED · started May 1, 2016ClinicalTrials.gov NCT03276195 · fetched Nov 12, 2026
- Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal CancerPHASE2 · WITHDRAWN · started Aug 1, 2009ClinicalTrials.gov NCT00954876 · fetched Nov 12, 2026